Article info

Download PDFPDF

978 Concordance of the FDA-approved companion diagnostic and a next-generation sequencing assay kit for assessing homologous recombination deficiency in ovarian cancer
Free

Authors

Citation

Weichert W, Qiu P, Lunceford J, et al
978 Concordance of the FDA-approved companion diagnostic and a next-generation sequencing assay kit for assessing homologous recombination deficiency in ovarian cancer

Publication history

  • First published October 25, 2021.
Online issue publication 
January 10, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.